Q4 2024 · CIK 1559771 Snapshot · — Export CSV
Manager file · ENG · Engaged Capital LLC

Glenn Welling - Engaged Capital

EDGAR CIK 1559771 ↗ · Filed · typical filing lag 45 days

Export CSV
Reported portfolio value
$486M
QoQ reported -21.1% · vs Q3 2024
Positions
8
1 new · 2 exited
Top 10 concentration
100.0%
largest position 23.6%
Position churn · Q4 2024
1 added · 3 trimmed
new positions 8.8% · exits 0.0% of book
Holdings · Q4 2024 · 8
Security Weight Δ wt Price* Shares Δ shares Value Action
1 VFC V F CORP 23.57% +6.3% $21 5.34M +0.0% $115M Held
2 VYX NCR VOYIX CORPORATION 16.42% +0.6% $14 5.77M -19.5% $79.87M Trimmed
3 NATL NCR ATLEOS CORPORATION 15.39% +1.5% $34 2.21M -26.7% $74.83M Trimmed
4 EVH EVOLENT HEALTH INC 12.50% -5.8% $11 5.40M +35.5% $60.80M Added
5 PTLO PORTILLOS INC 11.82% -1.5% $9 6.11M +0.0% $57.48M Held
6 0HW0 BRC INC 8.82% +1.3% $3 13.54M +0.0% $42.91M Held
7 GTLS CHART INDS INC 8.82% +8.8% $191 225K new $42.90M New
8 PRAA PRA GROUP INC 2.66% -3.5% $21 620K -63.6% $12.95M Trimmed
9 BL BLACKLINE INC 0.00% -5.5% — 0 610K → 0 $0 Exited
10 — NEVRO CORP 0.00% -2.2% — 0 2.44M → 0 $0 Exited

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • CHART INDS INC 8.82% · $42.90M
  • BLACKLINE INC was 5.45% · 610K sh
  • NEVRO CORP was 2.21% · 2.44M sh
  • Filing detail
    Period2024-12-31
    Accepted14 Feb 2025 · 14:00 ET
    Filing lag45 days
    Form13F-HR
    Information rows8
    Quarters on file11
    Portfolio value
    Q1 2023Q4 2023Q1 2024Q3 2024Q4 2024Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026$703M Q1 2023Q4 2023Q1 2024Q3 2024Q4 2024Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 202611
    Quarterly history · 11 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q3 2026 2026-09-30 $283M 9 27.9% 2 3 16 Nov 2026 ET 47
    Q2 2026 2026-06-30 $327M 10 23.1% 2 0 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $303M 8 26.2% 0 1 15 May 2026 ET 45
    Q4 2025 2025-12-31 $392M 9 24.5% 0 0 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $408M 9 20.8% 2 0 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $358M 7 19.1% 3 4 14 Aug 2025 ET 45
    Q4 2024 2024-12-31 $486M 8 23.6% 1 2 14 Feb 2025 ET 45
    Q3 2024 2024-09-30 $617M 9 18.3% 1 3 14 Nov 2024 ET 45
    Q1 2024 2024-03-31 $617M 11 17.3% 2 0 15 May 2024 ET 45
    Q4 2023 2023-12-31 $683M 9 15.8% 4 5 14 Feb 2024 ET 45
    Q1 2023 2023-03-31 $703M 10 21.4% — — 15 May 2023 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q1 2023
    -22.8%
    S&P 500 +87.7%
    Hit rate · latest book
    0%
    priced positions with positive return
    Priced coverage
    91%
    of reported stock value
    Q1 2023Q4 2023Q1 2024Q3 2024Q4 2024Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q3 2026 +0.0% +0.0% +0.0% 91% VFC +0.0%
    Q2 2026 +8.6% -4.1% +12.8% 95% VFC +38.3%
    Q1 2026 +11.6% +0.9% +10.7% 96% VFC +24.0%
    Q4 2025 -5.5% +9.6% -15.0% 96% EVH +78.1%
    Q3 2025 +19.7% +11.7% +8.0% 95% VFC +39.5%
    Q2 2025 +5.7% +16.7% -11.0% 95% VFC +62.1%
    Q4 2024 -14.2% +24.1% -38.4% 82% NATL +58.5%
    Q3 2024 -18.9% +28.0% -46.8% 90% NATL +64.3%
    Q1 2024 -12.7% +44.3% -56.9% 86% VFC +68.9%
    Q4 2023 -9.7% +53.8% -63.4% 86% NATL +123.8%
    Q1 2023 -22.8% +87.7% -110.5% 59% SHAK +4.3%
    Copy-trade simulation
    Hypothetical strategy
    -0.8%
    11 rebalances
    S&P 500 same window
    +87.7%
    excess -88.5%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.